Chronic administration of phencyclidine (PCP) in rats has been reported to induce a modest sensitization to the locomotor activating effects of PCP challenge. The underlying mechanisms are unknown, but they appear to be distinct from those of amphetamines and cocaine in that PCP-sensitization is not blocked by the selective NMDA antagonist MK-801. This laboratory has developed a chronic regimen of moderately high-dose PCP that results in a long- lasting, robust behavioral sensitization to low-dose PCP challenge. This dosage regimen also produces morphological and biochemical alterations in the olfactory tubercle and piriform cortex consistent with programmed cell death or apoptosis. Other preliminary studies suggest that chronic PCP induces an upregulation of the NR1 subunit of the NMDA receptor in several areas of the forebrain, including the olfactory and piriform regions, but not in areas such as the hippocampus or cerebellum. Functional studies using NMDA-stimulated neurotransmitter release generally support the in situ hybridization and immunocytochemistry data. Acute PCP is known to increase DA turnover in most terminal regions of the mesocortical and mesolimbic pathways, with the olfactory tubercle and piriform cortex being the most sensitive. The P.I. postulates that behavioral sensitization is associated with an altered DA release in the mesolimbic cortex and that the selective vulnerability of the olfactory tubercle and piriform region is due to both upregulated NMDA receptors in this region and to the neurotoxic effects of DA. Although acute high-dose PCP has previously been demonstrated to cause necrotic toxicity in the retrosplenial, posterior cingulate, entorhinal and possibly other limbic regions, the P.I. postulates that these two forms of toxicity can be distinguished pharmacologically. This application proposes a series of experiments that will use a combination of behavioral, pharmacological, biochemical and molecular techniques to further characterize PCP-induced behavioral sensitization, necrosis, programmed cell death, DA turnover and NMDA receptor upregulation in order to determine the relationship between these phenomena. There are four specific hypotheses that will be used to drive these experiments. An additional two hypotheses will be used first to obtain a """"""""fingerprint' of apoptotic death gene activation and second, to use this pattern along with other results to begin to establish an in vitro cortical culture model of chronic PCP- induced apoptosis. In the future, the P.I. would like to use this model to establish more precisely the mechanisms underlying PCP- induced cell death.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002073-21
Application #
6362788
Study Section
Special Emphasis Panel (ZRG1-IFCN-1 (01))
Program Officer
Frankenheim, Jerry
Project Start
1982-09-30
Project End
2004-02-29
Budget Start
2001-03-01
Budget End
2002-02-28
Support Year
21
Fiscal Year
2001
Total Cost
$148,310
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Timpe, Jennifer M; Wang, Cheng Z; Kim, Jisoo et al. (2014) ?-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor activation protects against phencyclidine-induced caspase-3 activity by activating voltage-gated calcium channels. J Neurosci Res 92:1785-91
García-Rodríguez, Olaya; Secades-Villa, Roberto; Flórez-Salamanca, Ludwing et al. (2013) Probability and predictors of relapse to smoking: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 132:479-85
Xia, Yan; Wang, Cheng Z; Liu, Jie et al. (2010) Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology 58:330-6
Lei, Gang; Anastasio, Noelle C; Fu, Yu et al. (2009) Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength. J Neurochem 109:1017-30
Anastasio, N C; Xia, Y; O'Connor, Z R et al. (2009) Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits. Neuroscience 163:1181-91
Lei, Gang; Xia, Yan; Johnson, Kenneth M (2008) The role of Akt-GSK-3beta signaling and synaptic strength in phencyclidine-induced neurodegeneration. Neuropsychopharmacology 33:1343-53
Wang, Cheng Z; Yang, San F; Xia, Yan et al. (2008) Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology 33:2442-55
Anastasio, Noelle C; Johnson, Kenneth M (2008) Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups. Pharmacol Biochem Behav 90:569-77
Xia, Yan; Wang, Cheng Z; Liu, Jie et al. (2008) Lithium protection of phencyclidine-induced neurotoxicity in developing brain: the role of phosphatidylinositol-3 kinase/Akt and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling pathways. J Pharmacol Exp Ther 326:838-48
Anastasio, Noelle C; Johnson, Kenneth M (2008) Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat. J Neurochem 104:1210-8

Showing the most recent 10 out of 53 publications